Topline data were announced from a phase 2/3 trial evaluating immune globulin intravenous (human) in patients with post-polio syndrome.
Philstar Life on MSN3h
EXPLAINER: What is myasthenia gravis?Sunshine Cruz recently revealed that she’s battling an autoimmune disease called myasthenia gravis. In an Instagram post, the ...
Sritha Rajupet, Director of the Post-Covid clinic at Stony Brook Medicine and Chair of Family, Population & Preventive ...
The Chinese Medical Association has released new guidelines for diagnosing and treating Mycoplasma pneumoniae in children.
Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...
Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...
Spanish plasma-derived medicines specialist Grifols (MCE: GRF) has announced positive results from its Phase II/III clinical ...
Findings showed after 52 weeks, significant improvements in 2MWD and 6MWD were seen with Flebogamma 5% DIF 1mg/kg compared with placebo. Topline data were announced from a phase 2/3 trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback